Exosome RNA Exosome RNA Research & Industry News
Regenerative medicine company Exopharm Limited (ASX:EX1) announces first dosing has occurred in the PLEXOVAL Phase I study using exosomes...
Read More »First Dosing in Exopharm’s PLEXOVAL Exosome Wound Healing Human Study
Don't Miss
- Extracellular vesicles and nanoparticles: emerging complexities
- Liquid Biopsy for Precision Oncology Summit
- CRISPR used to find cancer biomarkers in exosomes
- Biological Dynamics, Perlmutter Cancer Center at NYU Langone Health collaborate on pancreatic cancer research
- ExoSponge – rapid, cost-effective, porous polydimethylsiloxane (PDMS) based cancer-associated extracellular vesicle isolation
- Technological challenges of biomembrane-coated top-down cancer nanotherapy
- Isolation and characterisation of exosomes from Chinese hamster ovary (CHO) cells
- Cell-Based Drug Delivery Systems with Innate Homing Capability as a Novel Nanocarrier Platform
- Post-doc Position Available – Cancer and Infectious Disease Biomarkers
- NeuroDex receives MJFF grant to study blood test for Parkinson’s stratification based on extracellular vesicles